Custom Search Insider Trading Activity Insider Trading Activity

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Custom Search Insider Trading Activity

Updated Sep 15, 2020

Ticker
Company Name
Qty.
Price
Size ($)
Filing Date
Type
Δ Own
Own
Insider Names
Title
Trade Dates
Is Scheduled
Protara Therapeutics, Inc.
-2.55K
$19.40
-$49,540.80
-0.43%
585.6K
Sep 14
Protara Therapeutics, Inc.
-239.00
$18.00
-$4,302.00
-0.04%
588.15K
Sep 10
Protara Therapeutics, Inc.
-13.33K
$18.73
-$249,631.93
-2.22%
588.39K
Sep 8 - Sep 9
Protara Therapeutics, Inc.
-259.00
$20.58
-$5,330.64
-0.04%
601.72K
Sep 2 - Sep 3
Protara Therapeutics, Inc.
-771.00
$22.09
-$17,031.39
-0.13%
601.98K
Aug 28
Protara Therapeutics, Inc.
-2.03K
$22.39
-$45,543.12
-0.34%
602.75K
Aug 26 - Aug 27
Protara Therapeutics, Inc.
-3.44K
$22.85
-$78,496.37
-0.56%
604.79K
Aug 24 - Aug 25
Protara Therapeutics, Inc.
-510.00
$24.18
-$12,333.33
-0.08%
608.22K
Aug 20
Protara Therapeutics, Inc.
-200.00
$25.19
-$5,038.00
-0.03%
608.73K
Aug 18
Protara Therapeutics, Inc.
-2.25K
$25.10
-$56,433.28
-0.37%
608.93K
Aug 14 - Aug 17
Protara Therapeutics, Inc.
-3.83K
$26.33
-$100,909.86
-0.62%
611.18K
Jul 29 - Jul 30
Protara Therapeutics, Inc.
-25.93K
$30.48
-$790,611.82
-4.05%
615.01K
Jul 27 - Jul 28
Protara Therapeutics, Inc.
-2.34K
$26.53
-$62,168.97
-0.36%
640.95K
Jul 23 - Jul 24
Protara Therapeutics, Inc.
-1.59K
$26.71
-$42,598.18
-0.25%
643.29K
Jul 21 - Jul 22
Protara Therapeutics, Inc.
-4.33K
$26.79
-$116,009.52
-0.67%
644.89K
Jul 17 - Jul 20
Protara Therapeutics, Inc.
-4.80K
$27.28
-$131,077.04
-0.73%
649.22K
Jul 10 - Jul 13
Artara Therapeutics, Inc.
654.02K
—
—
∞
654.02K
Jan 9
Artara Therapeutics, Inc.
0
—
—
—
0

It looks like there's no data for these filter options. Maybe you'll be interested in these options instead.

Loading...